A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer
{{output}}
The identification of patients who are at high risk for irinotecan-related severe diarrhea and neutropenia is clinically important. We conducted the first genome-wide association study (GWAS) to search for novel susceptibility genes for irinotecan-related seve... ...
